Table of Contents
Chapter 1. Global Biomaterials Market Executive Summary
1.1. Global Biomaterials Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Application
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Biomaterials Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Biomaterials Market Dynamics
3.1. Market Drivers
3.1.1. Rising incidence of musculoskeletal and chronic skeletal conditions
3.1.2. Technological advancements in biomaterials
3.1.3. Aging global population
3.2. Market Challenges
3.2.1. Stringent regulatory approvals
3.2.2. High cost of advanced biomaterials
3.3. Market Opportunities
3.3.1. Increased R&D for novel biomaterials
3.3.2. Growing applications in tissue engineering and repair
Chapter 4. Global Biomaterials Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Biomaterials Market Size & Forecasts by Product 2022-2032
5.1. Segment Dashboard
5.2. Global Biomaterials Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Metallic
5.2.2. Natural
5.2.3. Ceramics
5.2.4. Polymers
Chapter 6. Global Biomaterials Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Biomaterials Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Cardiovascular
6.2.2. Ophthalmology
6.2.3. Dental
6.2.4. Orthopedic
6.2.5. Wound Healing
6.2.6. Tissue Engineering
6.2.7. Plastic Surgery
6.2.8. Neurology
6.2.9. Others
Chapter 7. Global Biomaterials Market Size & Forecasts by Region 2022-2032
7.1. North America Biomaterials Market
7.1.1. U.S. Biomaterials Market
7.1.1.1. Product breakdown size & forecasts, 2022-2032
7.1.1.2. Application breakdown size & forecasts, 2022-2032
7.1.2. Canada Biomaterials Market
7.2. Europe Biomaterials Market
7.2.1. U.K. Biomaterials Market
7.2.2. Germany Biomaterials Market
7.2.3. France Biomaterials Market
7.2.4. Spain Biomaterials Market
7.2.5. Italy Biomaterials Market
7.2.6. Rest of Europe Biomaterials Market
7.3. Asia-Pacific Biomaterials Market
7.3.1. China Biomaterials Market
7.3.2. India Biomaterials Market
7.3.3. Japan Biomaterials Market
7.3.4. Australia Biomaterials Market
7.3.5. South Korea Biomaterials Market
7.3.6. Rest of Asia Pacific Biomaterials Market
7.4. Latin America Biomaterials Market
7.4.1. Brazil Biomaterials Market
7.4.2. Mexico Biomaterials Market
7.4.3. Rest of Latin America Biomaterials Market
7.5. Middle East & Africa Biomaterials Market
7.5.1. Saudi Arabia Biomaterials Market
7.5.2. South Africa Biomaterials Market
7.5.3. Rest of Middle East & Africa Biomaterials Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Medtronic
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Evonik Industries AG
8.3.3. Carpenter Technology Corporation
8.3.4. Berkeley Advanced Biomaterials
8.3.5. Invibio Ltd.
8.3.6. Zimmer Biomet Holdings, Inc.
8.3.7. BASF SE
8.3.8. Covalon Technologies Ltd.
8.3.9. Stryker
8.3.10. Johnson & Johnson
8.3.11. Dentsply Sirona
8.3.12. CoorsTek Inc.
8.3.13. Corbion
8.3.14. Regenity Biosciences
8.3.15. Covalon Technologies Ltd.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes